(Q39272309)

10 September 2017

title

CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy (English)

1 reference

10 September 2017

author name string

Anita J Bechtholt-Gompf

1

1 reference

10 September 2017

Karen L Smith

2

1 reference

10 September 2017

Catherine S John

3

1 reference

10 September 2017

Hannah H Kang

4

1 reference

10 September 2017

William A Carlezon

5

1 reference

10 September 2017

Bruce M Cohen

6

1 reference

10 September 2017

Dost Ongür

7

1 reference

10 September 2017

language of work or name

1 reference

28 January 2011

1 reference

10 September 2017

1 reference

10 September 2017

volume

215

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

689-695

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Measuring normal and pathological anxiety-like behaviour in mice: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Automated tests for measuring the effects of antidepressants in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Effects of chronic fluoxetine in animal models of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Behavioral effects of ketamine and toxic interactions with psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Ketamine produces lasting disruptions in encoding of sensory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Ketamine concentrations during cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Lack of persistent effects of ketamine in rodent models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Genetic differences in a tail suspension test for evaluating antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2169-8

Intravenous ketamine therapy in a patient with a treatment-resistant major depression

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21274700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The tail suspension test: a new method for screening antidepressants in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21274700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-011-2169-8

1 reference

10 September 2017

1 reference